| scholarly article | Q13442814 |
| P50 | author | Bin Shan | Q42738140 |
| Takashi Takahashi | Q56945207 | ||
| P2093 | author name string | Zhen Lin | |
| Erik K Flemington | |||
| Joseph A Lasky | |||
| Hong T Nguyen | |||
| Ross C Klingsberg | |||
| Mark D Sides | |||
| Kristin A Gordon | |||
| P2860 | cites work | Latent herpesvirus infection augments experimental pulmonary fibrosis | Q39342306 |
| Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression. | Q39962123 | ||
| Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo | Q39978694 | ||
| Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway | Q40024497 | ||
| Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo | Q40274082 | ||
| Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells | Q40495577 | ||
| RECK is a target of Epstein–Barr virus latent membrane protein 1 | Q40616852 | ||
| Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies | Q40623874 | ||
| Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling | Q40687983 | ||
| Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. | Q41081957 | ||
| Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation | Q41736955 | ||
| Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? | Q44307938 | ||
| The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis | Q45750246 | ||
| American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) | Q73445075 | ||
| Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis | Q73734162 | ||
| MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits | Q77103881 | ||
| MMP expression and abnormal lung permeability are important determinants of outcome in IPF | Q82176972 | ||
| Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma | Q24298635 | ||
| Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation | Q24316905 | ||
| Complete sequence and genomic analysis of murine gammaherpesvirus 68 | Q24672530 | ||
| TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) | Q24813751 | ||
| Mechanisms of TGF-beta signaling from cell membrane to the nucleus | Q27860785 | ||
| Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias | Q28143296 | ||
| Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy | Q28200083 | ||
| Regulation of immune responses by TGF-beta | Q28271433 | ||
| Cytoplasmic PML function in TGF-beta signalling | Q28281152 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix | Q29619797 | ||
| Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. | Q33281716 | ||
| Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. | Q33605234 | ||
| Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells | Q33807504 | ||
| Epithelial origin of myofibroblasts during fibrosis in the lung | Q33996286 | ||
| The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases | Q34099074 | ||
| LMP1 structure and signal transduction | Q34415978 | ||
| TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease | Q34581113 | ||
| Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways | Q34721581 | ||
| Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro | Q34928535 | ||
| Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis | Q35027515 | ||
| Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis | Q35533486 | ||
| Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice | Q35855163 | ||
| Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice | Q36327458 | ||
| Regulation of matrix metalloproteinase gene expression | Q36682744 | ||
| Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. | Q36777948 | ||
| Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer | Q38300727 | ||
| P433 | issue | 6 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| membrane protein | Q423042 | ||
| P304 | page(s) | 852-862 | |
| P577 | publication date | 2010-08-06 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells | |
| P478 | volume | 44 |
| Q39537817 | Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells |
| Q35758535 | CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice |
| Q92155923 | Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1 |
| Q36294959 | Current and novel drug therapies for idiopathic pulmonary fibrosis |
| Q55001674 | Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma. |
| Q26824760 | EMT and interstitial lung disease: a mysterious relationship |
| Q41584964 | Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition. |
| Q64085716 | Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk |
| Q38869012 | Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies |
| Q58803477 | Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis |
| Q34611385 | Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis |
| Q39657805 | Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. |
| Q36187673 | Microbes-induced EMT at the crossroad of inflammation and cancer |
| Q40101851 | Microbial infection, inflammation and epithelial ovarian cancer |
| Q37152982 | Modulation of bacterial pathogenesis by oppressive aging factors: insights into host-pneumococcal interaction strategies |
| Q90028399 | NADPH Oxidase Inhibition in Fibrotic Pathologies |
| Q38568602 | Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma |
| Q38842811 | Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition |
| Q42031550 | Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis |
| Q35850237 | Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis |
| Q90537703 | Risk factors for the development of idiopathic pulmonary fibrosis: A review |
| Q54112589 | The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling. |
| Q52332667 | The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. |
| Q38805572 | Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers |
| Q33678879 | Yiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF-β/Smad Pathway. |
Search more.